You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

 

Online download statistics by month:

Online download statistics by month: January 2022 to November 2025

AbstractFullPdf
Jan 2022346357134
Feb 2022253255115
Mar 202223824184
Apr 202214615278
May 202212312357
Jun 202213013438
Jul 202213013134
Aug 202213913973
Sep 202214014083
Oct 202211312049
Nov 2022909323
Dec 2022808120
Jan 2023747421
Feb 2023939431
Mar 2023646546
Apr 2023404019
May 2023383825
Jun 2023292915
Jul 2023212220
Aug 2023414116
Sep 2023485230
Oct 2023515121
Nov 2023727221
Dec 202316016214
Jan 2024272715
Feb 2024464619
Mar 2024323253
Apr 2024363632
May 2024353524
Jun 2024373618
Jul 2024525323
Aug 2024323355
Sep 20245253219
Oct 2024545422
Nov 2024383927
Dec 2024424320
Jan 2025474821
Feb 2025212130
Mar 2025323232
Apr 2025717125
May 2025353823
Jun 2025222213
Jul 2025110
Nov 2025110
Total337234271738